On this page
This entry or formulation may be investigational and may not correspond to an FDA-approved product; safety and efficacy may not have been established. Kairo lists it for identification and record-keeping only.
Overview
Product & regulatory status
Research and diagnostic contexts differ from ongoing wellness treatment.
Ghrelin signaling
GHRP-2 stimulates the GH-secretagogue receptor. The experiment assessed both GH secretion and eating behavior, two distinct consequences of this pathway. [1]
What the evidence shows
Appetite experiment
Seven lean healthy men received GHRP-2 or saline in a controlled experiment. They ate more at a buffet meal after GHRP-2, and their GH levels increased. [1]
What this does not show
A single meal response and hormone rise do not demonstrate sustained muscle growth, improved recovery, or favorable long-term body composition. [1]
What remains unknown
The evidence here does not establish safe chronic combinations with other GH-axis compounds or benefits for people pursuing weight loss.
Safety
FDA safety assessment
FDA describes immune-response concerns and serious events reported with GHRP-2; causation was not established. [2]
Studied exposure
The experiment used a controlled subcutaneous infusion. It does not validate a self-selected bolus schedule, nasal preparation, or blend. [1]
Understanding product quality
Compounded drugs are not FDA-approved finished products. Poor preparation can cause contamination or incorrect strength. A catalog entry or a research paper is not a quality assessment of your product. [3]
When to seek urgent help
Severe allergic symptoms such as trouble breathing, throat or tongue swelling, or fainting need immediate help. Call 911 or your local emergency number. This is general emergency information, not a complete list of risks for this compound. [4]
A starting point for discussion
This is not a complete list of adverse effects or interactions. Your health history, other medicines, and the exact formulation matter. Missing safety data is not evidence of safety.
Common questions
Could a GH-releasing compound increase hunger?
Yes. The cited GHRP-2 experiment measured increased food intake, illustrating why a drug’s actual outcomes matter more than its category.
Questions for your clinician
Does the evidence match my condition and this exact product? What risks or interactions matter for me? How would we assess whether it is helping?
Sources
- Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men2005 · Primary research · PubMed
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety RisksFDA · Compound-specific safety assessment
- Compounding and the FDA: Questions and AnswersFDA · product quality and regulation
- AnaphylaxisMedlinePlus · recognizing an emergency
Educational information, not a recommendation to use a compound. Kairo does not give dosing advice. Review decisions with a licensed healthcare professional.